BackChemours Company Overview
Chemours Company

Chemours Company Target Price

Analysts' average 12-month price target for Chemours Company is $28.

Get informed when a big investor buys or sells

+ Follow

Share Price

$17.93

Average Target Price

$28.0056.2% upside

9 analysts in the last 4 months

High: $30 | Low: $21

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-13Alembic Global$3067.3% upsideOpen
2026-05-11Morgan StanleyVincent Andrews$2117.1% upsideOpen
2026-05-11RBC Capital$2961.7% upsideOpen
2026-05-08UBS$3067.3% upsideOpen
2026-05-06Mizuho SecuritiesJohn Roberts$3067.3% upsideOpen
2026-04-28Truist FinancialPeter Osterland$3067.3% upsideOpen
2026-04-10RBC CapitalArun Viswanathan$2645% upsideOpen
2026-04-09UBS$2961.7% upsideOpen
2026-04-09Truist Financial$2750.6% upsideOpen
2026-02-23Mizuho Securities$175.2% downsideOpen
2026-02-23JefferiesLaurence Alexander$175.2% downsideOpen
2026-02-23UBS$2328.3% upsideOpen
2026-02-23BMO Capital$196% upsideOpen
2026-02-23Morgan StanleyVincent Andrews$175.2% downsideOpen
2026-01-21Truist Financial$2117.1% upsideOpen
2026-01-19BMO CapitalJohn McNulty$2011.5% upsideOpen
2026-01-16RBC Capital$180.4% upsideOpen
2025-11-10Truist FinancialPeter Osterland$180.4% upsideOpen
2025-10-16Mizuho SecuritiesJohn Roberts$180.4% upsideOpen
2025-10-14RBC Capital$196% upsideOpen
2025-10-06UBSJoshua Spector$2117.1% upsideOpen
2025-09-23Mizuho SecuritiesJohn Roberts$196% upsideOpen
2025-05-07UBSJoshua Spector$175.2% downsideOpen
2025-04-15Mizuho SecuritiesJohn Roberts$1516.3% downsideOpen
2024-10-11RBC CapitalArun Viswanathan$2856.2% upsideOpen
2024-10-07BMO CapitalJohn McNulty$3278.5% upsideOpen
2024-08-06BMO CapitalJohn McNulty$3067.3% upsideOpen
2024-06-07Mizuho SecuritiesJohn Roberts$2539.4% upsideOpen
2024-05-29UBSRich Hilliker$3172.9% upsideOpen
2024-04-09BMO CapitalJohn McNulty$3489.6% upsideOpen
2024-04-01UBSJoshua Spector$2856.2% upsideOpen
2024-04-01CFRAEmily Nassedd Mitsch$180.4% upsideOpen
2024-03-13D.A. DavidsonLinda Bolton Weiser$2433.9% upsideOpen
2023-12-01RBC CapitalArun Viswanathan$40123.1% upsideOpen
2023-10-30Morgan StanleyVincent Andrews$3384% upsideOpen
2023-01-10RBC CapitalArun Viswanathan$3384% upsideOpen
2022-05-04RBC Capital$48167.7% upsideOpen
2021-05-20Bank of America SecuritiesMatthew DeYoe$42134.2% upsideOpen
2021-05-10Morgan StanleyVincent Andrews$3595.2% upsideOpen
2021-05-06Argus ResearchDavid Coleman$40123.1% upsideOpen

Chemours Company (CC) FAQ

Chemours Company's target price stands at $28. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $28 for CC implies 56.2% upside versus today's price ($17.93). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Chemours Company's target price evolved across reporting periods, while the comparison chart places CC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Consumer Discretionary, target price is commonly used to spot outliers. Chemours Company's reading of $28 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.